PQ 745
745. Deputy Róisín Shortall asked the Minister for Health the position regarding a new anti-calcitonin gene-related peptide, CGRP, medication for the preventative treatment of chronic migraine; if the National Centre for Pharmacoeconomics, NCPE, has completed its full health technology assessment; and if he will make a statement on the matter. [18900/19]
Introduced
8 May 2019
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
8 May 2019
Summary
745. Deputy Róisín Shortall asked the Minister for Health the position regarding a new anti-calcitonin gene-related peptide, CGRP, medication for the preventative treatment of chronic migraine; if the National Centre for Pharmacoeconomics, NCPE, has completed its full health technology assessment; and if he will make a statement on the matter. [18900/19]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Medicinal Products Reimbursement
Medicinal Products Reimbursement
xml · EN · 8 May 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2019-05-08/745/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2019-05-08/pq_745